Intervention not reported
Progression‐free survival/time to progression (randomised participants) ‐ trials of metastatic breast cancer participants unselected for TNBC · women with metastatic breast cancer unselected for triple‐negative breast cancer (TNBC)
The intervention showed no clear difference in progression‐free survival/time to progression (randomised… (moderate certainty).
1 finding from 1 review
- HR 0.92 [0.84, 1.01]13 studies · 1745 participantsModerate